Citius Oncology

(NASDAQ) CTOR

Current Price$0.84

Market Cap$77.08M

Since IPO (2022)-92%

5 YearN/A

1 Year-5%

1 Month-8%

Citius Oncology Financials at a Glance

Market Cap

$77.08M

Revenue (TTM)

$5.61M

Net Income (TTM)

$42.51M

EPS (TTM)

$-0.47

P/E Ratio

-1.78

Dividend

$0.00

Beta (Volatility)

-1.80 (Low)

Dividend

$0.00

Beta (Volatility)

-1.80 (Low)

Price

$0.84

Volume

48,237

Open

$0.82

Price

$0.84

Volume

48,237

Open

$0.82

Previous Close

$0.84

Daily Range

$0.79 - $0.84

52-Week Range

$0.49 - $6.19

Dividend

$0.00

Beta (Volatility)

-1.80 (Low)

Price

$0.84

Volume

48,237

Open

$0.82

Previous Close

$0.84

Daily Range

$0.79 - $0.84

52-Week Range

$0.49 - $6.19

CTOR News

Citius Oncology Beats Fiscal Q3 EPS

Motley Fool Markets TeamAug 12, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Citius Oncology

Industry

Biotechnology

Sector

Health Care

CEO

Leonard L. Mazur, MBA

Website

citiusonc.com

Headquarters

New York City, NY 10170, US

CTOR Financials

Key Financial Metrics (TTM)

Gross Margin

80%

Operating Margin

-8%

Net Income Margin

-8%

Return on Equity

-120%

Return on Capital

-1%

Return on Assets

-42%

Earnings Yield

-56.18%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$77.08M

Shares Outstanding

92.98M

Volume

48.24K

Avg. Volume

231.48K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$23.52M

EBITDA

$23.49M

Operating Cash Flow

$5.49M

Capital Expenditure

$4.00

Free Cash Flow

$5.49M

Cash & ST Invst.

$3.92M

Total Debt

$3.80M

Citius Oncology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$1.67M

N/A

Gross Profit

$1.34M

N/A

Gross Margin

80.27%

N/A

Market Cap

$77.08M

N/A

Market Cap/Employee

$270.46K

N/A

Employees

285

N/A

Net Income

$26.61M

-244.0%

EBITDA

$28.61M

-283.0%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$1.17M

+69.3%

Accounts Receivable

$1.08M

N/A

Inventory

$22.66M

+47.7%

Long Term Debt

$3.80M

+0.0%

Short Term Debt

$0.00

N/A

Return on Assets

-42.22%

N/A

Return on Invested Capital

-1.04%

N/A

Free Cash Flow

$3.97M

N/A

Operating Cash Flow

$3.97M

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MCRBSeres Therapeutics, Inc.

MCRBSeres Therapeutics, Inc.$7.92-1.61%

LNSRLENSAR, Inc.

LNSRLENSAR, Inc.$6.09+2.35%

ACTUActuate Therapeutics Inc

ACTUActuate Therapeutics Inc$2.38-1.65%

VORVor Biopharma Inc.

VORVor Biopharma Inc.$14.33-4.72%

SCLXScilex Holding Company

SCLXScilex Holding Company$6.02+1.69%

OWLTOwlet, Inc.

OWLTOwlet, Inc.$5.79+0.87%

APLTApplied Therapeutics, Inc.

APLTApplied Therapeutics, Inc.$0.10+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

INTCIntel

INTCIntel$119.84+0.01%

ONDSOndas

ONDSOndas$9.06-0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.84+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$41.50-0.01%

MDLNMedline

MDLNMedline$37.01-0.00%

MARAMara Holdings

MARAMara Holdings$13.81+0.02%

Questions About CTOR

What is the current price of Citius Oncology?

Citius Oncology is trading at $0.84 per share.

What is the 52-week range for Citius Oncology?

Over the past 52 weeks, Citius Oncology has traded between $0.49 and $6.19.

How much debt does Citius Oncology have?

As of the most recent reporting period, Citius Oncology reported total debt of $3.80M.

How much cash does Citius Oncology have on hand?

Citius Oncology reported $2.63M in cash and cash equivalents in its most recent financial results.

What is Citius Oncology’s dividend yield?

Citius Oncology does not currently have a dividend yield.

Citius Oncology

Citius Oncology Financials at a Glance

CTOR News

Citius Oncology Beats Fiscal Q3 EPS

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Citius Oncology

CTOR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Citius Oncology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CTOR

What is the current price of Citius Oncology?

What is the 52-week range for Citius Oncology?

How much debt does Citius Oncology have?

How much cash does Citius Oncology have on hand?

What is Citius Oncology’s dividend yield?

Premium Investing Services